
Join to View Full Profile
111 E 210th StBronx, NY 10467
Dr. Kordes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Trials
- International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013) Start of enrollment: 2018 Jul 17
- ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study Start of enrollment: 2020 Aug 21
Roles: Contact, Principal Investigator
- Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors Start of enrollment: 2021 Dec 03
Roles: Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation o...Martin Hasselblatt, Christian Thomas, Aniello Federico, Karolina Nemes, Pascal D Johann
The American Journal of Surgical Pathology. 2022-09-01 - ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.Till Holsten, Annika Bronsema, Dominik Sturm, Felix Sahm, Stefan Rutkowski
Pediatric Blood & Cancer. 2022-08-01 - 6 citationsLow-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC.Martin Hasselblatt, Christian Thomas, Aniello Federico, Susanne Bens, Mats Hellström
Neuropathology and Applied Neurobiology. 2022-06-01
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: